Psychopharmacologic approach to the medically ill patient.
Generally, there are few absolute contraindications to the use of somatic psychiatric therapies in the medically or surgically ill. A knowledge of psychotropic drugs, of their predictable effects on organs, of their interactions with other medications, and of the idiosyncratic reactions that they often produce allows the consultation psychiatrist to treat the seriously ill patient safely. Close collaboration with other consultants is essential to maximize therapeutic benefits.
D000368:Aged; D000375:Aging; D000661:Amphetamine / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000378:metabolism; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects; D001569:Benzodiazepines / Q000009:adverse effects; D006321:Heart / Q000187:drug effects; D006760:Hospitalization; D006801:Humans; D008094:Lithium / Q000009:adverse effects; D008168:Lung / Q000187:drug effects; D001523:Mental Disorders / Q000150:complications / Q000188:drug therapy; D010349:Patient Compliance; D011570:Psychiatry; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D012017:Referral and Consultation
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D008094:Lithium; D000661:Amphetamine